Cognition Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M Cash from investing activities -58 K-30 K——— — Cash from financing activities 329 K11.38 M1.3 M752 K33.92 M 47.35 M Free cash flow -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M

新闻

认知治疗公司与FDA就路易体痴呆症药物举行会议

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

认知治疗公司的DLB药物在二期临床试验中显示积极结果

Cognition’s DLB drug shows positive results in phase 2 trial

认知治疗公司完成扩展获取计划的患者招募

Cognition Therapeutics completes enrollment in expanded access program

认知治疗公司概述阿尔茨海默病药物的三期试验计划

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

认知治疗公司完成阿尔茨海默病药物试验招募

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?